Carinox Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Loratadine 5 mg, pseudoephedrine sulphate 120 mg

Indications/Uses

Symptomatic relief of allergic rhinitis & common cold including nasal congestion, sneezing, rhinorrhea, pruritus & lacrimation.

Click to view Carinox detailed prescribing information

Dosage/Direction for Use

Adult & childn ≥12 yr 1 cap bd.

Click to view Carinox detailed prescribing information

Overdosage

View Carinox overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity or idiosyncrasy to loratadine, pseudoephedrine sulphate, adrenergic agents or drugs of similar chemical structure. Narrow-angle glaucoma, urinary retention, severe HTN & CAD, hyperthyroidism. Patients receiving MAOI therapy or w/in 14 days of discontinuation.

Click to view Carinox detailed prescribing information

Special Precautions

Discontinue use approx 48 hr prior to skin testing. Glaucoma, stenosing peptic ulcer, pyloroduodenal obstruction, prostatic hypertrophy or bladder neck obstruction, CV disease, increased IOP or DM. Concomitant use w/ digitalis. Prolonged & high-dose use. Avoid abrupt w/drawal. Severe hepatic impairment. Pregnancy & lactation. Childn <12 yr. Elderly ≥60 yr.

Click to view Carinox detailed prescribing information

Use In Pregnancy & Lactation

Click to view Carinox detailed prescribing information

Adverse Reactions

Insomnia, dry mouth, headache, somnolence.

Click to view Carinox detailed prescribing information

Drug Interactions

Increased plasma conc w/ ketoconazole, erythromycin, cimetidine. Hypertensive reactions including hypertensive crises w/ MAOIs. Reduced antihypertensive effects of methyldopa, mecamylamine, reserpine, veratum alkaloids. Increased ectopic pacemaker activity w/ digitalis. Increased absorption rate w/ antacids. Decreased absorption rate w/ kaolin. Concomitant use w/ β-blockers.

Click to view Carinox detailed prescribing information

Storage

View Carinox storage conditions for details to ensure optimal shelf-life.

Description

View Carinox description for details of the chemical structure and excipients (inactive components).

Action

View Carinox mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Cough & Cold Preparations / Antihistamines & Antiallergics

ATC Classification

R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic sympathomimetic preparations used as nasal decongestants.

Regulatory Classification

Presentation/Packing

Form

Carinox cap

Packing/Price

50 × 10's

Carinox

loratadine + pseudoephedrine

Manufacturer:

Duopharma Manufacturing (Bangi)

Distributor:

Duopharma Marketing